PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 12, 2024Immunity & Ageing20 citationsOpen Access

Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort

View Full Paper
EWEdric WinfordJLJenny LutshumbaBMBarbara J. Martin

Key Points

Key points are not available for this paper at this time.

Abstract

The immune response changes during aging and the progression of Alzheimer's disease (AD) and related dementia (ADRD). Terminally differentiated effector memory T cells (called T

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Winford et al. (2024) studied this question.

synapsesocial.com/papers/68e64f8fb6db6435875e0762https://doi.org/10.1186/s12979-024-00443-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease2016 · 429 citations
  2. 2Phenotype and function of human T lymphocyte subsets: Consensus and issues2008 · 721 citations
  3. 3An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry2017 · 89 citations
  4. 4CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease2012 · 330 citations
  5. 5Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic2022 · 82 citations